Skip to content

Circio Holding ASA Sustainability Reports

Circio Holding ASA is a biotechnology company developing circular RNA expression systems for next-generation gene and cell therapy. Its proprietary circVec platform is designed to enhance the potency and durability of gene expressions within targeted cells.

Sector: Professional & technical services

Country: Norway

Exchange: Oslo Børs

LEI: 5967007LIEEXZXFYNS31

FIGI: BBG002GMP1L6

13 reports from 2017 to 2025